ACEP’s Pawan Goyal, MD, MHA; Sandy Schneider, MD, FACEP; Cynthia Singh, MS; and several other leaders met…
Over the last year, ACEP’s strong federal advocacy efforts have been rewarded with numerous, and significant, legislative…
On Oct. 24, President Donald Trump signed a sweeping legislative package of bills to address the nation’s…
I am writing in response to the article “Buprenorphine Explained, And Opioid Addiction Treatment Tips” published in…
On Oct. 4, 2018, ACEP participated in a meeting along with 10 other provider groups to discuss…
There are multiple forms for buprenorphine (commonly called bupe), and this can prove confusing. Although we may…
Suboxone is a sublingual (SL) film dosage form containing a partial opioid agonist (buprenorphine) and an opioid antagonist (naloxone) for treating opioid dependence.1…
In September, Dr. Kivela led a teleconference discussion with the American College of Physicians (ACP) on ACEP…
The Department of Justice (DOJ) hosted a White House event last month to announce the release of…
On Oct. 3, Congress passed critical opioid legislation. Included in the package are the “Alternatives to Opioids…